LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used ...
"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...
SALT LAKE CITY - LifeVantage (NASDAQ ... released a study today showing the combined use of two of its products, Protandim® Nrf2 Synergizer® and MindBody GLP-1 Systemâ„¢, coined the Healthy ...
SALT LAKE CITY - LifeVantage (NASDAQ ... which includes the MindBody GLP-1 Systemâ„¢ and Protandim® Nrf2 Synergizer®. The study highlighted that the combination of these products activated ...